Menu

Report Library

All Reports
Datamonitor Healthcare CV&Met: Anemia in Chronic Kidney Disease Disease Coverage

Retail Price: $22,000.00

*BioMedTracker Subscriber Price: $15,000.00 - click here to log in

January 11, 2018

Chronic kidney disease (CKD) is characterized by decreased kidney function and kidney damage. Damaged renal tissue has a diminished ability to produce erythropoietin, a hormone that stimulates red blood cell production. Consequently, patients with CKD often experience anemia, defined as a reduction in red blood cells or hemoglobin levels. The risk of anemia increases as CKD progresses and kidney function declines.

This Datamonitor Healthcare Disease Coverage report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.

Disease Group Covered: Hematology
Indications Covered: Alport Syndrome
Edema
End-Stage Renal Disease (ESRD)
Focal Segmental Glomerulosclerosis (FSGS)
Hyperoxaluria
Hyperphosphatemia
Immunoglobulin A (IgA) Nephropathy (Berger's Disease)
Polycystic Kidney Disease
Renal Disease / Renal Failure
Renal Toxicity Due To Oncology Treatment
Back to the top Back to the top